Violation Tracker Parent Company Summary

Parent Company Name: 
Novartis
Ownership Structure: 
publicly traded (ticker symbol NVS)
Headquartered in: 
Switzerland
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$1,345,146,943
Number of records: 
38
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$501,638,2505
kickbacks and bribery$390,000,0002
employment discrimination$183,051,5943
wage and hour violation$99,199,4432
False Claims Act and related$96,974,30710
Foreign Corrupt Practices Act$25,000,0001
price-fixing or anti-competitive practices$20,350,0002
HHS civil monetary penalties$12,870,0002
export control violation$8,100,0001
economic sanction violation$7,785,6502
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

ALCON; ALCON PHARMACEUTICALS AND ALCON LABS; CHIRON; CIBA Vision; Geneva Pharmaceuticals; NOVARTIS; Novartis Corporation; Novartis Corporation and Alcon Laboratories; NOVARTIS VACCINES AND DIAGNOSTICS AND NOVARTIS PHARMACEUTICALS; Sandoz

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Novartis Pharmaceuticals Corporation off-label or unapproved promotion of medical products 2010 FDA $422,500,000
Novartis Pharmaceuticals kickbacks and bribery 2015 USAO $390,000,000
Novartis Corporation employment discrimination 2010 private lawsuit-federal $175,000,000
Novartis wage and hour violation 2012 private lawsuit-federal $99,000,000
Novartis Pharmaceuticals Corporation off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $88,258,694
Novartis Pharmaceuticals Corporation kickbacks and bribery 2015 MULTI-AG (*) $83,129,754
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation off-label or unapproved promotion of medical products 2010 FDA $72,500,000
Sandoz, Inc. False Claims Act and related 2011 MS-AG $30,110,618
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $29,000,000
Novartis AG Foreign Corrupt Practices Act 2016 SEC $25,000,000
Novartis Pharmaceuticals False Claims Act and related 2019 IL-AG $21,280,356
Sandoz False Claims Act and related 2009 KY-AG $16,000,000
Geneva Pharmaceuticals price-fixing or anti-competitive practices 2005 MULTI-AG $15,350,000
Sandoz False Claims Act and related 2013 LA-AG $13,100,000
Sandoz, Inc. HHS civil monetary penalties 2015 HHSOIG $12,640,000
Alcon Pharmaceuticals Ltd. and Alcon Laboratories, Inc. export control violation 2016 BIS $8,100,000
Novartis Corporation and Alcon Laboratories employment discrimination 2016 private lawsuit-federal $8,000,000
Alcon Laboratories, Inc economic sanction violation 2016 OFAC $7,617,150
Novartis False Claims Act and related 2013 LA-AG $7,000,000
Novartis Pharmaceuticals off-label or unapproved promotion of medical products 2012 TX-AG $6,638,250
CIBA Vision price-fixing or anti-competitive practices 2000 MULTI-AG $5,000,000
Novartis Pharmaceuticals Corporation False Claims Act and related 2010 HI-AG $3,333,333
Novartis Pharmaceuticals Corp. False Claims Act and related 2012 KY-AG $2,750,000
Sandoz Inc. False Claims Act and related 2010 ID-AG $1,650,000
Alcon False Claims Act and related 2013 LA-AG $1,000,000
Novartis Pharmaceuticals Corp. False Claims Act and related 2013 ID-AG $750,000
Sandoz, Inc. HHS civil monetary penalties 2011 HHSOIG $230,000
Alcon Research, Ltd. wage and hour violation 2011 WHD $199,443
Chiron Corporation Ltd economic sanction violation 2004 OFAC $168,500
CHIRON CORPORATION workplace safety or health violation 2000 OSHA $90,140
Novartis Pharmaceuticals employment discrimination 2013 OFCCP $51,594
ALCON RESEARCH, LTD workplace safety or health violation 2010 OSHA $30,300
ALCON LABORATORIES, INC. workplace safety or health violation 2016 OSHA $16,480
NOVARTIS PRODUCTS environmental violation 2000 EPA $13,200
NOVARTIS PHARMACEUTICALS CORPORATION benefit plan administrator violation 2006 EBSA $10,001
Novartis Animal Health US, Inc. environmental violation 2006 EPA $6,500
NOVARTIS CONSUMER HEALTH INC. workplace safety or health violation 2013 OSHA $6,078
NOVARTIS CONSUMER HEALTH, INC. environmental violation 2000 EPA $5,000
Download results as CSV or XML